Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 3
3(60.0%)
N/A
2(40.0%)
5Total
Phase 3(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06824909Recruiting

Endoscopic Ultrasound-guided Fine-needle Aspiration of Solid Pancreatic Lesions With Rapid Staining of Cytological Smears Followed by Whole Slide Scanning and Artificial Intelligence Diagnosis: A Prospective, Multicenter Study.

Role: collaborator

NCT06527807Recruiting

Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and Puerperium

Role: collaborator

NCT04251286Unknown

Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network

Role: collaborator

NCT04287660Phase 3Unknown

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

Role: collaborator

NCT05059379Phase 3Recruiting

Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer

Role: collaborator

NCT03766490Not ApplicableUnknown

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

Role: collaborator

NCT02430207Not ApplicableUnknown

Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein

Role: collaborator

NCT00643877Phase 3Unknown

Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer

Role: collaborator

All 8 trials loaded